Kossel Medtech will continue to develop excellent products to serve human health,our #PTCA Balloon catheter #PTA balloon catheters #DE stent system will help more and more patients be out of pain!

Recently, Suzhou held a biomedical industry innovation cluster promotion meeting，the Suzhou Government is making effort to build an innovative cluster of the biomedical industry with international competitiveness and global influence.

As a platform enterprise with full-scale production and research and development capabilities of vascular interventional devices, Kossel Medtech has been successfully selected into the second batch of potential landmark enterprises in the biopharmaceutical industry in Suzhou.

Potential landmark companies generally have leading technical level and innovation capabilities, and have significant competitive advantages and vitality potential in subdivided tracks. They are the “vanguard” and “new force” of innovation and development.

Being selected into the second batch of potential landmark enterprises in the biopharmaceutical industry in Suzhou is an authoritative recognition of the innovation capability and technical level to Kossel, which means that Kossel has significant competitive advantage in the subdivision of vascular interventional devices.